Leader Cooling Pain Relief

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is performed with clean hands and that the affected area is clean and dry prior to application.

For children under 2 years of age, it is advised to consult a healthcare professional before use to determine the appropriate course of action.

Contraindications

The product is contraindicated in the following situations:

Application to wounds or damaged skin is prohibited due to the potential for adverse effects. The use of this product in conjunction with other ointments, creams, sprays, or liniments is not recommended, as it may lead to unpredictable interactions. Application to irritated skin or in cases where excessive irritation develops is contraindicated to prevent further skin damage. Tight bandaging is not advised, as it may exacerbate irritation or impede circulation. Additionally, the use of heating pads or heating devices in conjunction with this product is contraindicated due to the risk of increased irritation or adverse reactions.

Warnings and Precautions

For external use only.

Healthcare professionals should advise patients to consult a physician prior to use if they have sensitive skin. During the application of this product, it is imperative to avoid contact with the eyes and to refrain from applying it to wounds or damaged skin. The product should not be used concurrently with other ointments, creams, sprays, or liniments, nor should it be applied to irritated skin or if excessive irritation develops. Additionally, patients should be instructed not to bandage the area tightly and to wash their hands thoroughly with cool water after application. The use of heating pads or other heating devices in conjunction with this product is contraindicated.

Patients should be informed to discontinue use and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Side Effects

Patients using this product may experience various adverse reactions. It is important to note that this product is for external use only. Individuals with sensitive skin should consult a doctor before use to avoid potential irritation.

While using this product, patients should take precautions to avoid contact with the eyes and should not apply it to wounds, damaged skin, or irritated areas. The product should not be used in conjunction with other ointments, creams, sprays, or liniments, and should not be bandaged tightly. If excessive irritation develops, patients are advised to discontinue use. It is also recommended that patients wash their hands with cool water after application and avoid using heating pads or heating devices concurrently.

Patients should stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Additionally, the product is flammable and should be kept away from fire or flame. Pregnant or breastfeeding individuals should seek advice from a health professional prior to use. It is crucial to keep this product out of reach of children; if swallowed, immediate medical assistance should be sought or the Poison Control Center (1-800-222-1222) should be contacted.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Leader Cooling Pain Relief (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

It is important to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Should ingestion occur, immediate medical assistance is required. Healthcare professionals should advise caregivers to contact the Poison Control Center at 1-800-222-1222 without delay.

Prompt action is crucial in managing potential overdosage situations to mitigate risks and ensure patient safety.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been provided in the insert. Additionally, there is no information available regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact the Poison Control Center at 1-800-222-1222 immediately.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using this product, patients should be cautioned to avoid contact with the eyes and not to apply it to wounds or damaged skin. It is important to inform patients that they should not use this product in conjunction with other ointments, creams, sprays, or liniments, and to refrain from applying it to irritated skin or if excessive irritation develops. Additionally, patients should be advised against bandaging the area tightly and should wash their hands with cool water after use. They should also be warned not to use the product with heating pads or heating devices.

Finally, healthcare providers should encourage patients to ask a doctor before use if they have sensitive skin to ensure safe and effective use of the product.

Storage and Handling

The product is supplied in a configuration that ensures optimal preservation of its integrity. It is essential to store the product in a cool, dry place, ensuring that the lid is closed tightly to prevent contamination and maintain efficacy. Proper storage conditions are critical for the product's stability and longevity.

Additional Clinical Information

Patients aged 2 years and older are advised to apply the product to the affected area no more than 3 to 4 times daily, while those under 2 years should consult a doctor prior to use. Clinicians should counsel patients that the product is for external use only and to seek medical advice if they have sensitive skin.

When using the product, patients must avoid contact with eyes and should not apply it to wounds, damaged, or irritated skin. It is important not to use the product in conjunction with other ointments, creams, sprays, or liniments, and to refrain from tight bandaging. Patients should wash their hands with cool water after application and avoid using heating pads or devices. They should discontinue use and consult a doctor if the condition worsens, symptoms persist beyond 7 days, or if symptoms clear and recur within a few days. Pregnant or breastfeeding individuals should seek advice from a health professional before use. The product should be kept out of reach of children, and in case of ingestion, medical help or contact with the Poison Control Center (1-800-222-1222) is necessary.

Drug Information (PDF)

This file contains official product information for Leader Cooling Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)